Peter Caravan, PhD, will present “Development of Molecular Probes for Imaging Thrombosis, Fibrosis and Fibrogenesis” at the PET Radiotracer Translation and Resource Center (PET-RTRC) inaugural seminar on July 2 at 12 p.m. The seminar will be held in Connor Auditorium at the Farrell Learning and Teaching Center.
Caravan is the director of the Institute for Innovation in Imaging (i3) at Massachusetts General Hospital and associate professor of radiology at Harvard Medical School. He leads a multidisciplinary and translational molecular imaging lab focused on the invention of novel molecular probes and their broad applications in cardiovascular, pulmonary, renal and hepatic diseases, as well as in cancers. His research spans novel chemistry technologies to advanced MRI and PET imaging in animal models, to applications in patient populations.
Caravan received a doctorate in inorganic chemistry from the University of British Columbia. Following postdoctoral work at the EPFL (Switzerland), he worked in the industry developing targeted MR probes. He joined the faculty of Harvard Medical School in 2007 and has been a continuously funded NIH researcher.